Clinical Trials Browser

Myeloproliferative Disorders × guadecitabine × Myeloid × Clear all

NCT03075826 2022-05-05

A Phase II Study of SGI-110 in Philadelphia-Negative Myeloproliferative Neoplasms

Phase 2 Completed

22 enrolled 8 charts

Myeloproliferative Disorders